Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities-Reference-Cited by-同舟云学术

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities

Published:2020-02 Issue:2 Volume:77 Page:158-166
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Lu-Yao Grace,Nikita Nikita,Keith Scott W.,Nightingale Ginah,Gandhi Krupa,Hegarty Sarah E.,Rebbeck Timothy R.,Chapman Andrew,Kantoff Philip W.,Cullen Jennifer,Gomella Leonard,Kelly William Kevin

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy;Mulders;Eur Urol,2014

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

3. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy;Beer;N Engl J Med,2014

4. Prostate cancer in the elderly patient;Fung;J Clin Oncol,2014

5. Reducing patient eligibility criteria in cancer clinical trials;George;J Clin Oncol,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer;JAMA Oncology;2024-07-01

2. Outcomes in studies regarding older patients with prostate cancer: A systematic review;Journal of Geriatric Oncology;2024-06

3. EORTC 2238 “De-Escalate”: a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors;Frontiers in Oncology;2024-05-08

4. Androgen Deprivation Therapy/Androgen Receptor Signaling Inhibitor Treatments for Prostate Cancer: Pathophysiology and Review of Effects on Cardiovascular Disease;Southern Medical Journal;2024-05

5. Interference with mitochondrial metabolism could serve as a potential therapeutic strategy for advanced prostate cancer;PLOS ONE;2024-04-10